BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mishra K, Shah A, Patel K, Ghosh K, Bharadva S. Seroprevalence of HBV, HCV and HIV-1 and Correlation with Molecular Markers among Multi-Transfused Thalassemia Patients in Western India. Mediterr J Hematol Infect Dis 2020;12:e2020038. [PMID: 32670516 DOI: 10.4084/MJHID.2020.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shah A, Bharadva S, Patel P, Mishra K. Novel Diagnostic Approach and Safe Blood Transfusion Practices for Thalassemia: A Vital Role of a Blood Centre in Western India. Hepatitis B 2022. [DOI: 10.5772/intechopen.101672] [Reference Citation Analysis]
2 Riaz M, Abbas M, Rasool G, Baig IS, Mahmood Z, Munir N, Mahmood Tahir I, Ali Shah SM, Akram M. Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review. Int J Immunopathol Pharmacol 2022;36:3946320221096909. [PMID: 35452334 DOI: 10.1177/03946320221096909] [Reference Citation Analysis]
3 Mirzaei G, Shamsasenjan K, Jafari B, Bagherizadeh Y, Sadafzadeh A, Bannazadeh-Baghi H, Sadeghi-Deylamdeh Z, Jafari-Sales A. Prevalence of HBV and HCV infection in beta-thalassemia major patients of Tabriz city, Iran. New Microbes New Infect 2021;43:100912. [PMID: 34401191 DOI: 10.1016/j.nmni.2021.100912] [Reference Citation Analysis]
4 Kandi V, Vinjamuri SR, Tanikella BP. Hepatitis C Viral Infection Among Beta-Thalassemia Patients: A Study From the Centre for Excellence in Thalassemia and Other Blood Disorders. Cureus 2021;13:e16207. [PMID: 34367809 DOI: 10.7759/cureus.16207] [Reference Citation Analysis]